<DOC>
	<DOCNO>NCT00444106</DOCNO>
	<brief_summary>To evaluate potential effect artemether- lumefantrine auditory function</brief_summary>
	<brief_title>Evaluation Potential Effect Artemether - Lumefantrine Malaria Drugs Auditory Function</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Lumefantrine</mesh_term>
	<mesh_term>Artemether</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Artemether-lumefantrine combination</mesh_term>
	<mesh_term>Artesunate</mesh_term>
	<mesh_term>Mefloquine</mesh_term>
	<mesh_term>Proguanil</mesh_term>
	<mesh_term>Atovaquone</mesh_term>
	<mesh_term>Atovaquone , proguanil drug combination</mesh_term>
	<criteria>Inclusion Criteria 12 year age old Accepts Healthy Volunteers P. falciparum parasitemia 1,000 100,000 parasites/μl History fever presence fever ( temperature ≥ 37.5°C ) Exclusion Criteria Signs/symptoms severe/complicated malaria Ingestion various antimalarial drug , antibiotic previous 2 week 2 month History drugrelated hear impairment Abnormal hearing function study entry Exposure sustain loud noise , selfreport , within past 24 hour Present ear problem Pregnant lactating ( urine test βHCG ) perform woman child bear age ) Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Malaria</keyword>
	<keyword>hearing</keyword>
	<keyword>co-artemether</keyword>
	<keyword>auditory</keyword>
	<keyword>Plasmodium falciparum</keyword>
	<keyword>marsh fever</keyword>
	<keyword>Plasmodium infection</keyword>
	<keyword>remittent fever</keyword>
	<keyword>paludism</keyword>
	<keyword>artemether</keyword>
	<keyword>artemisinins</keyword>
	<keyword>benflumetol</keyword>
	<keyword>lumefantrine</keyword>
</DOC>